PMGC Holdings Inc. (NASDAQ:ELAB) Sees Large Decrease in Short Interest

PMGC Holdings Inc. (NASDAQ:ELAB) was the target of a significant decrease in short interest in July. As of July 31st, there was short interest totaling 440,372 shares, a decrease of 45.6% from the July 15th total of 809,201 shares. Currently, 38.0% of the shares of the stock are short sold. Based on an average daily volume of 847,193 shares, the short-interest ratio is presently 0.5 days.

PMGC Stock Down 4.9%

Shares of NASDAQ ELAB opened at $0.83 on Wednesday. The company has a market capitalization of $961,970.00, a P/E ratio of -0.01 and a beta of -0.25. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.45 and a quick ratio of 1.43. The company has a 50 day simple moving average of $1.11 and a 200-day simple moving average of $3.65. PMGC has a 1 year low of $0.82 and a 1 year high of $309.12.

PMGC (NASDAQ:ELAB) last released its quarterly earnings data on Friday, August 14th. The company reported ($0.61) EPS for the quarter. The business had revenue of $1.31 million during the quarter. PMGC had a negative net margin of 522.92% and a negative return on equity of 140.68%.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of PMGC in a research report on Friday, June 26th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has an average rating of “Sell”.

About PMGC

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.